参考文献/References:
[1] Nast A, Dréno B, Bettoli V, et al. European evidencebased (S3) guidelines for the treatment of acne[J]. Journal of the European Academy of Dermatology and Venereology, 2012, 26(s1):1-29. [2] Halvorsen J A, Stern R S, Dalgard F, et al. Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: A population-based study[J]. Journal of Investigative Dermatology, 2011, 131(2):363-370. [3] Misery L. Consequences of psychological distress in adolescents with acne[J]. Journal of Investigative Dermatology, 2011, 131(2):290-292. [4] Kurokawa I, Danby F W, Qiang J, et al. New developments in our understanding of acne pathogenesis and treatment[J]. Experimental Dermatology, 2010, 18(10):821-832. [5] Zouboulis C C, Jourdan E, Picardo M. Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions[J]. Journal of the European Academy of Dermatology & Venereology, 2014, 28(5):527-532. [6] Jeremy A H, Holland D B, Roberts S G, et al. Inflammatory events are involved in acne lesion initiation[J]. Journal of Investigative Dermatology, 2003, 121(1):20-27. [7] Dreno B, Gollnick H P M, Kang S, et al. Understanding innate immunity and inflammation in acne: implications for management[J]. J Eur Acad Dermatol Venereol, 2015, 29(S4):3-11. [8] Louise S J, Tomasz K, Terence K, et al. Toll-like receptor 2 activation and comedogenesis: implications for the pathogenesis of acne[J]. Bmc Dermatology, 2013, 13(1):10-10. [9] Smith R N, Braue A, Varigos G A, et al. The effect of a low glycemic load diet on acne vulgaris and the fatty acid composition of skin surface triglycerides[J]. Journal of Dermatological Science, 2008, 50(1):41-52. [10] Downie M M, Kealey T. Human sebaceous glands engage in aerobic glycolysis and glutaminolysis[J]. British Journal of Dermatology, 2015, 151(2):320-327. [11] Chen W, Yang C C, Sheu H M, et al. Expression of peroxisome proliferator-activated receptor and CCAAT/ enhancer binding protein transcription factors in cultured human sebocytes[J]. Journal of Investigative Dermatology, 2003, 121(3):441. [12] Makrantonaki E , Zouboulis C C . Testosterone metabolism to 5α-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferator-activated receptor ligand linoleic acid in human sebocytes[J]. BritishJournal of Dermatology, 2007, 156. [13] Goldberg J L, Dabade T S, Davis S A, et al. Changing age of acne vulgaris visits: another sign of earlier puberty[J]. Pediatric Dermatology, 2011, 28(6):645-648. [14] Eichenfield L F, Krakowski A C, Piggott C, et al. Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne[J]. Pediatrics, 2013, 3(Supplement):163-186. [15] Ayhan M, Sancak B, Karaduman A, et al. Colonization of neonate skin by Malassezia species: relationship with neonatal cephalic pustulosis[J]. Journal of the American Academy of Dermatology, 2007, 57(6):1012-1018. [16] Serna-Tamayo C, Janniger C K, Micali G, et al. Neonatal and infantile acne vulgaris: an update[J]. Cutis, 2014, 94(1):13-16. [17] Lucky A W, Biro F M, Huster G A, et al. Acne vulgaris in premenarchal girls. An early sign of puberty associated with rising levels of dehydroepiandrosterone[J]. Archives of Dermatology, 1994, 130(3):308. [18] Davis S A, Sandoval L F, Gustafson C J, et al. Treatment of preadolescent acne in the United States: an analysis of nationally representative data[J]. Pediatric Dermatology, 2013, 30(6):689-694. [19] Leccia M T, Auffret N, Poli F, et al. Topical acne treatments in Europe and the issue of antimicrobial resistance[J]. Journal of the European Academy of Dermatology & Venereology, 2015, 29(8):1485-1492. [20] Group W, Zaenglein A L, Pathy A L, et al. Guidelines of care for the management of acne vulgaris[J]. Journal of the American Academy of Dermatology, 2016, 74(5):945-973. [21] Two A M, Wu W, Gallo R L, et al. Rosacea: part II. Topical and systemic therapies in the treatment of rosacea[J]. Journal of the American Academy of Dermatology, 2015, 72(5):761-770. [22] Two A M, Wu W, Gallo R L, et al. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors.[J]. Journal of the American Academy of Dermatology, 2015, 72(5):749-758. [23] Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea[J]. Journal of the American Academy of Dermatology, 2002, 46(4):584-587. [24] Aldrich N, Gerstenblith M, Fu P, et al. Genetic vs environmental factors that correlate with rosacea: A cohort-based survey of twins[J]. Jama Dermatology, 2015, 151(11):1213. [25] Chang A L S, Raber I, Xu J, et al. Assessment of the genetic basis of rosacea by genome-wide association study[J]. Journal of Investigative Dermatology, 2015, 135(6):1548- 1555. [26] Rainer B M, Fischer A H, Luz Felipe Da Silva D, et al. Rosacea is associated with chronic systemic diseases in a skin severity-dependent manner: results of a case-control study.[J]. Journal of the American Academy of Dermatology, 2015, 73(4):604-608. [27] Hua T C, Chung P I, Chen Y J, et al. Cardiovascular comorbidities in patients with rosacea: A nationwide case-control study from Taiwan[J]. Journal of the American Academy of Dermatology, 2015, 73(2):249-254. [28] Egeberg A, Hansen P R, Gislason G H, et al. Clustering of autoimmune diseases in patients with rosacea[J]. Journal of the American Academy of Dermatology, 2016, 74(4):667- 672. [29] Sulk M, Seeliger S, Aubert J, et al. Distribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosacea[J]. Journal of Investigative Dermatology, 2012, 132(4):1253-1262. [30] Yamasaki K, Kanada K, Macleod D T, et al. TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes[J]. Journal of Investigative Dermatology, 2011, 131(3):688-697. [31] Yamasaki K, Schauber J, Coda A, et al. Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin[J]. Faseb Journal Official Publication of the Federation of American Societies for Experimental Biology, 2006, 20(12):2068-2080. [32] Yamasaki K, Nardo A D, Bardan A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea[J]. Nature Medicine, 2007, 13(8): 975-980. [33] Muto Y, Wang Z, Vanderberghe M, et al. Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea[J]. Journal of Investigative Dermatology, 2014, 134(11):2728-2736. [34] Steinhoff M, Buddenkotte J, Aubert J, et al. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.[J]. Journal of Investigative Dermatology Symposium Proceedings, 2011, 15(1):2. [35] Buhl T, Sulk M, Nowak P, et al. Molecular and morphological characterization of inflammatory infiltrate in rosacea reveals activation of Th1/Th17 pathways[J]. Journal of Investigative Dermatology, 2015, 135(9): 2198-2208.